LetterLetter
Open Access

Enhancing FIT-based colorectal cancer screening through risk prediction: a comparative evaluation of 17 models in a large Chinese cohort

Le Wang, Weimiao Wu, Bin Liu, Chen Zhu, Yumeng Ding, Yi Zhou, Weiwei Chen, Lijuan Dai, Xueni Chen, Yuefan Shen, Tingting Pan, Xiaohui Sun, Huizhang Li, Dong Hang, Yingying Mao, Partha Basu and Lingbin Du
Cancer Biology & Medicine March 2026, 20250702; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0702

References

  1. 1.↵
    2. Bray F,
    3. Laversanne M,
    4. Sung H,
    5. Ferlay J,
    6. Siegel RL,
    7. Soerjomataram I, et al.
    Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024; 74: 229–63.
    OpenUrlCrossRefPubMed
  2. 2.↵
    1. US Preventive Services Task Force;
    2. Davidson KW,
    3. Barry MJ,
    4. Mangione CM,
    5. Cabana M,
    6. Caughey AB,
    7. Davis EM, et al.
    Screening for colorectal cancer: US Preventive Services Task Force recommendation statement. JAMA. 2021; 325: 1965–77.
    OpenUrlCrossRefPubMed
  3. 3.↵
    2. Lansdorp-Vogelaar I,
    3. Meester R,
    4. de Jonge L,
    5. Buron A,
    6. Haug U,
    7. Senore C.
    Risk-stratified strategies in population screening for colorectal cancer. Int J Cancer. 2022; 150: 397–405.
    OpenUrlPubMed
  4. 4.↵
    2. Wang L,
    3. Liu C,
    4. Wang Y,
    5. Du L.
    Cost-effectiveness of risk-tailored screening strategy for colorectal cancer: a systematic review. J Gastroenterol Hepatol. 2022; 37: 1235–43.
    OpenUrlPubMed
  5. 5.↵
    2. Kang JHE,
    3. Levine E,
    4. Fleet A,
    5. Padilla MS,
    6. Lee JK,
    7. Harrison H, et al.
    Systematic review: risk prediction models for metachronous advanced colorectal neoplasia after polypectomy. J Gastroenterol Hepatol. 2024; 39: 2533–44.
    OpenUrlPubMed
  6. 6.
    2. Usher-Smith JA,
    3. Walter FM,
    4. Emery JD,
    5. Win AK,
    6. Griffin SJ.
    Risk prediction models for colorectal cancer: a systematic review. Cancer Prev Res (Phila). 2016; 9: 13–26.
    OpenUrlAbstract/FREE Full Text
  7. 7.
    2. Peng L,
    3. Weigl K,
    4. Boakye D,
    5. Brenner H.
    Risk scores for predicting advanced colorectal neoplasia in the average-risk population: a systematic review and meta-analysis. Am J Gastroenterol. 2018; 113: 1788–800.
    OpenUrlPubMed
  8. 8.↵
    2. Hampton JS,
    3. Kenny RPW,
    4. Rees CJ,
    5. Hamilton W,
    6. Eastaugh C,
    7. Richmond C, et al.
    The performance of FIT-based and other risk prediction models for colorectal neoplasia in symptomatic patients: a systematic review. EClinicalMedicine. 2023; 64: 102204.
  9. 9.↵
    2. Hang D,
    3. Sun D,
    4. Du L,
    5. Huang J,
    6. Li J,
    7. Zhu C, et al.
    Development and evaluation of a risk prediction tool for risk-adapted screening of colorectal cancer in China. Cancer Lett. 2024; 597: 217057.
  10. 10.↵
    2. Hang D,
    3. Zhu C,
    4. Yang X,
    5. He J,
    6. Li H,
    7. Pan T, et al.
    Colorectal cancer screening based on fecal immunochemical test and risk assessment: a population-based study including two million participants in China. J Epidemiol. 2025; 35: 297–302.
    OpenUrlPubMed
  11. 11.↵
    2. Imperiale TF,
    3. Monahan PO,
    4. Stump TE,
    5. Glowinski EA,
    6. Ransohoff DF.
    Derivation and validation of a scoring system to stratify risk for advanced colorectal neoplasia in asymptomatic adults: a cross-sectional study. Ann Intern Med. 2015; 163: 339–46.
    OpenUrlCrossRefPubMed
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools

Jump to section